Bayview Pharmacy is pleased to present our compounded formulation of Metronidazole 125 mg/ml and Nystatin 25,000 Units/ml Vaginal Cream. This unique blend is specifically designed to combat a range of gynecological conditions such as bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.

Metronidazole, an antibiotic, operates by eliminating bacteria and other microorganisms. Nystatin, an antifungal, functions by inhibiting the growth of fungi. The combination of these two potent medications provides an effective treatment for the aforementioned conditions.

This semisolid formulation is dispensed in a tube, designed for convenient and precise application in the vaginal area. It delivers the medication directly to the affected area, providing therapeutic effects for specific gynecological conditions. It is crucial to adhere to the instructions provided by your healthcare provider when using this medication.

Please be aware that this medication should not be used during pregnancy or while breastfeeding. Always consult with your healthcare provider before starting any new medication regimen.

If you have any queries about this formulation or how it can be utilized to treat your condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to assisting you in finding the most suitable treatment option for your needs. Please note that while we strive to provide comprehensive information, we do not claim to be the most knowledgeable compounding pharmacy known to man. Our goal is to provide quality care and reliable service to our patients.

Metronidazole 125 mg/ml/Nystatin 25,000 Units/ml Vaginal Cream is a compounded formulation designed for the treatment of vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV). This semisolid formulation is dispensed in a tube for convenient and precise application in the vaginal area, delivering medication or providing therapeutic effects for these specific gynecological conditions.

Metronidazole, an antibiotic, works by inhibiting the growth of bacteria, while Nystatin, an antifungal, works by stopping the growth of fungi. This combination of medications is effective in treating both VVC and BV, providing a comprehensive solution for these conditions.

Patients should be aware that this medication may cause side effects such as nausea, vomiting, headache, and abdominal pain. It is also important to note that this medication may interact with other medications, including anticoagulants, anticonvulsants, and certain antibiotics. Therefore, patients should inform their healthcare provider of any other medications they are currently taking before using this medication.

Prescribers should also be aware of the potential interactions of this medication with other drugs, such as anticoagulants, anticonvulsants, and certain antibiotics. Additionally, they should be mindful of the potential side effects such as nausea, vomiting, headache, and abdominal pain. It is recommended that prescribers monitor patients for any signs of adverse reactions while using this medication.

If you have any questions about Metronidazole 125 mg/ml/Nystatin 25,000 Units/ml Vaginal Cream or its interactions, please do not hesitate to reach out for further information.

Metronidazole 125 mg/ml/Nystatin 25,000 Units/ml Vaginal Cream is a specially compounded medication designed to treat a range of gynecological conditions. This unique formulation combines the potent antibiotic metronidazole with the antifungal agent nystatin, creating a dual-action treatment that effectively combats both bacterial and fungal infections.

Metronidazole works by eliminating bacteria and other microorganisms, while nystatin inhibits the growth of fungi. This makes the cream particularly effective in treating conditions such as bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.

When using this medication, it is crucial to adhere to the instructions provided by your healthcare provider. The cream is typically applied to the affected area twice daily, usually in the morning and evening. It is essential to continue using the cream for the full duration of the treatment course, even if symptoms appear to improve after a few days. This ensures that the infection is completely eradicated and helps prevent recurrence.

While undergoing treatment with Metronidazole 125 mg/ml/Nystatin 25,000 Units/ml Vaginal Cream, it is advisable to abstain from sexual contact. This is because the medication can potentially be transferred to a partner, which may affect their health.

If you have any queries or concerns about using Metronidazole 125 mg/ml/Nystatin 25,000 Units/ml Vaginal Cream, please do not hesitate to contact your healthcare provider or pharmacist. They are best equipped to provide you with the necessary guidance and support to ensure you get the maximum benefit from your treatment.

This compounded formulation of Metronidazole 125 mg/ml and Nystatin 25,000 Units/ml Vaginal Cream is a semisolid preparation, dispensed in a tube for easy and precise application in the vaginal area. It is specifically designed to deliver medication and provide therapeutic effects for certain gynecological conditions.

The formulation is primarily used to treat a range of infections including bacterial vaginosis, candidiasis, trichomoniasis, gardnerella, and clostridial infections. However, it is crucial to understand that this formulation should not be used to treat any other type of infection, as its effectiveness may not be guaranteed. Furthermore, it should not be used in conjunction with other medications without medical advice, as this could potentially increase the risk of side effects.

Patients are strongly advised to consult with their healthcare provider before using this formulation to ensure it is the most suitable treatment for their condition. It is also important to note that this formulation should not be used in patients who are pregnant or breastfeeding, due to potential risks to the fetus or infant. Additionally, it should not be used in patients with a known hypersensitivity to any of the ingredients in the formulation.

If you have any questions or concerns about the use of this formulation, please do not hesitate to contact your healthcare provider or pharmacist for further information and guidance.